- Home
- ADEA vs CERT Comparison
ADEA vs CERT Comparison
Compare ADEA & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADEA
- CERT
- Stock Information
- Founded
- ADEA 1990
- CERT 2008
- Country
- ADEA United States
- CERT United States
- Employees
- ADEA N/A
- CERT N/A
- Industry
- ADEA Computer Software: Prepackaged Software
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- ADEA Technology
- CERT Technology
- Exchange
- ADEA Nasdaq
- CERT Nasdaq
- Market Cap
- ADEA 1.6B
- CERT 1.7B
- IPO Year
- ADEA N/A
- CERT 2020
- Fundamental
- Price
- ADEA $15.65
- CERT $11.28
- Analyst Decision
- ADEA Strong Buy
- CERT Buy
- Analyst Count
- ADEA 4
- CERT 7
- Target Price
- ADEA $19.50
- CERT $15.00
- AVG Volume (30 Days)
- ADEA 466.1K
- CERT 1.3M
- Earning Date
- ADEA 11-06-2025
- CERT 11-05-2025
- Dividend Yield
- ADEA 1.27%
- CERT N/A
- EPS Growth
- ADEA 80.44
- CERT N/A
- EPS
- ADEA 0.74
- CERT 0.05
- Revenue
- ADEA $378,674,000.00
- CERT $405,755,000.00
- Revenue This Year
- ADEA $9.49
- CERT $12.38
- Revenue Next Year
- ADEA $4.94
- CERT $7.49
- P/E Ratio
- ADEA $21.22
- CERT $226.96
- Revenue Growth
- ADEA 5.47
- CERT 11.61
- 52 Week Low
- ADEA $10.59
- CERT $8.64
- 52 Week High
- ADEA $17.46
- CERT $15.69
- Technical
- Relative Strength Index (RSI)
- ADEA 61.46
- CERT 56.35
- Support Level
- ADEA $15.09
- CERT $10.23
- Resistance Level
- ADEA $15.62
- CERT $11.09
- Average True Range (ATR)
- ADEA 0.39
- CERT 0.41
- MACD
- ADEA -0.02
- CERT 0.03
- Stochastic Oscillator
- ADEA 86.41
- CERT 88.33
About ADEA Adeia Inc.
Adeia Inc is a consumer and entertainment product/solutions licensing company. Its only operating segment being Intellectual Property (IP) Licensing. In the IP segment, the company licenses innovations to companies in the broader entertainment industry, and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.